These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34800932)

  • 21. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens.
    Ogawa Y; Yonou H; Hokama S; Oda M; Morozumi M; Sugaya K
    Front Biosci; 2003 Sep; 8():a167-76. PubMed ID: 12957883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethnic background has minimal impact on the etiology of nephrolithiasis.
    Maloney ME; Springhart WP; Ekeruo WO; Young MD; Enemchukwu CU; Preminger GM
    J Urol; 2005 Jun; 173(6):2001-4. PubMed ID: 15879804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Urinary Stone Chemical Compositions and Prevalence of Metabolic Disorders Among Urolithiasis Patients in Northern Sri Lanka: A Prospective Study.
    Balasingam B; Varothayan S; Rajendra S; Satchithanantham V; Sarma ST; Sri Pandurangana S; Vithyasahar S; Jothini T; Vishnuja S; Paramanathan S
    Cureus; 2024 Jun; 16(6):e63377. PubMed ID: 39077304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 24-hour urine composition prior to and after stone removal in nephrolithiasis: a prospective observational study.
    Zhu W; Zhang X; Lu S; Özsoy M; Zhou Z; Huang Z; Ai G; Zeng G
    Minerva Urol Nephrol; 2024 Jun; 76(3):351-356. PubMed ID: 36779823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
    Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
    Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features.
    McPhail EF; Gettman MT; Patterson DE; Rangel LJ; Krambeck AE
    Urology; 2012 Feb; 79(2):277-81. PubMed ID: 22014971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
    Curhan GC; Willett WC; Speizer FE; Stampfer MJ
    Kidney Int; 2001 Jun; 59(6):2290-8. PubMed ID: 11380833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The altered composition of gut microbiota and biochemical features as well as dietary patterns in a southern Chinese population with recurrent renal calcium oxalate stones.
    Cao C; Jin X; Ding Q; Zhu J; Yang D; Fan B
    Urolithiasis; 2023 Jul; 51(1):95. PubMed ID: 37458823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic evaluation of children with urolithiasis.
    Gouru VR; Pogula VR; Vaddi SP; Manne V; Byram R; Kadiyala LS
    Urol Ann; 2018; 10(1):94-99. PubMed ID: 29416283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of urinary abnormalities in urolithiasis patients: A study from North India.
    Kumar R; Kapoor R; Mittal B; Kumar A; Mittal RD
    Indian J Clin Biochem; 2003 Jul; 18(2):209-15. PubMed ID: 23105414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic abnormalities in patients with nephrolithiasis: comparison of first-episode with recurrent cases in Southern Iran.
    Hosseini MM; Eshraghian A; Dehghanian I; Irani D; Amini M
    Int Urol Nephrol; 2010 Mar; 42(1):127-31. PubMed ID: 19548107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 24-Hour urine collection for first time pediatric stone formers: Is it worth it?
    Carnes K; Howe A; Feustel PJ; Listman JA; White M; Kogan BA
    J Pediatr Urol; 2021 Jun; 17(3):387.e1-387.e7. PubMed ID: 33762156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What Factors Drive Staghorn
    Winoker JS; Bamberger JN; Chandhoke RA; Atallah W; Gupta M
    J Endourol; 2019 Nov; 33(11):954-959. PubMed ID: 31436119
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum and 24-hour urinary tests cost-effectiveness in stone formers.
    Mohammadi A; Farabi H; Baghdadabad LZ; Narouie B; Reis LO; Aghamir SMK
    BMC Urol; 2023 Aug; 23(1):141. PubMed ID: 37635222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.